Antimicrobial susceptibility of anaerobic bacteria in Bulgaria

Anaerobe

Volumn 15, Issue 4, 2009, Pages 127-132

  Marina, M ^a   Ivanova, M ^a   Kantardjiev, T ^a  

^a NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

Anaerobic bacteria; Antimicrobial agents; Susceptibility

Indexed keywords

AMOXICILLIN; AMPICILLIN; AZITHROMYCIN; AZLOCILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CARBENICILLIN; CEFAMANDOLE; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFOXITIN; CEPHALOSPORIN; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; IMIPENEM; JOSAMYCIN; MACROLIDE; MEROPENEM; METRONIDAZOLE; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; ROXITHROMYCIN; SULBACTAM; TETRACYCLINE;

AGAR DILUTION; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; BULGARIA; CONTROLLED STUDY; ENZYME ACTIVITY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; BULGARIA; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS;

ANIMALIA; BACTEROIDES FRAGILIS;

EID: 67651039815     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anaerobe.2009.03.002     Document Type: Article

References (38)

1. Aldridge K.E., Gelfand M., Reller L.B., Ayers L.W., Pierson C.L., Schoenknecht F., et al. A five-year multicenter study of the susceptibility of the Bacteroides fragilis group isolates to cephalosporins, cephamins, penicillins, clindamycin, and metronidazole in USA. Diagn Microbiol Infect Dis 18 (1994) 235-241
2. Aldridge K.A. Multicenter survey of the changing in vitro susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species. Antimicrobial Agents Chemother 45 (2001) 1238-1243
3. Appleman M.D., Heseltine P.N., and Cherubin C.E. Epidemiology, antimicrobial susceptibility, pathogenicity and significance of Bacteroides fragilis group organisms isolated at Los Angeles county-University of Southern California Medical Center. Rev Infect Dis 13 (1991) 12-18
4. Betriu C., Campos E., Cabronero C., Rodriguez-Avial C., and Picazzo JJ. Susceptibilities of species of the Bacteroides fragilis group to 10 antimicrobial agents. Antimicrobial Agents Chemother 34 (1990) 671-673
5. Bourgault A.M., Harding G.K., Smith J.A., Horsman G.B., Marrie T.J., and Lamothe F. Survey of anaerobic susceptibility patterns in Canada. Antimicrobial Agents Chemother 30 (1986) 798-801
6. Breuil J., Burnat C., Patey O., and Dublanchet A. Survey of Bacteroides fragilis susceptibility in France. J Antimicrob Chemother 254 (1989) 69-75
7. Citron D., Goldstein E.J.C., Kenner M.A., Burnham L.B., and Inderlied C.B. Activity of ampicillin/sulbactam, ticarcillin/clavulanate, clarithromycin, and eleven other antimicrobial agents against anaerobic bacteria isolated from infections in children. Clin Infect Dis 20 2 (1995) 356-360
8. D'Amato R., Hochstein L., and Frankel H. In vitro activity of cefoperazone/sulbactam and other antimicrobials against anaerobic bacteria. Diagn Microbiol Infect Dis 13 (1990) 51-55
9. De Almeida A.E., and De Uzeda M. Susceptibility to five antimicrobial agents of strains of Bacteroides fragilis group isolated in Brazil. Antimicrobial Agents Chemother 31 (1986) 617-618
10. Dubreuil L. Activite in vitro de la roxithromycine, nouveau macrolide semi-synthetique envers les anaerobies stricts. Pathol Biol 34 (1986) 440-444
11. Dubreuil L., Derriennic M., Sedallian A., Romond C., and Courtieu A.L. Evolution in antibiotic susceptibility of Bacteroides fragilis group strains in France based on periodic surveys. Infection 17 (1989) 197-200
12. Falagas M.E., and Siakavellas E. Bacteroides, Prevotella and Porphyromonas species: a review of antibiotic resistance and therapeutic options. Int J antimicrob Agents 15 (2000) 1-9
13. Fille M. Bacteroides fragilis group: trends in resistance. Curr Microbiol 52 (2006) 153-157
14. Finegold S.M. Anaerobes: problems and controversies in bacteriology, infections, and susceptibility testing. Rev Infect Dis 12 2 (1990) 223-229
15. Garcia-Rodriguez J.A., Garcia-Sanchez J.E., and Prieto-Prieto J. Josamycin alone and in combination against anaerobic bacteria. Drugs Exp Clin Res VIII/3/ (1982) 285-288
16. Garcia-Rodriguez J.A., Garcia-Sanchez J.E., and Munoz-Bellido J.L. Antimicrobial resistance in anaerobic bacteria: current situation. Anaerobe 1 (1995) 69-80
17. Goldstein E.J.C., Citron D., Goldman R., Claros M., and Hunt-Gerardo S. United States hospital survey of anaerobic culture and susceptibility methods II. Anaerobe 6 (1995) 309-314
18. Goldstein E.J.C., and Citron D. National hospital survey of anaerobic culture and susceptibility methods. Anaerobe 14 (2008) 68-72
19. Hecht D.W., Osmolski J.R., and Keefe J.P. Variation of susceptibility of Bacteroides fragilis group isolates from six Chicago hospitals. Clin Infect Dis 16 4 (1993) 357-360
20. Hecht D.W. Evolution of the anaerobic susceptibility testing in the United States. Clin Infect Dis 35 1 (2002) 28-35
21. Hecht D.W. Prevalence of antibiotic resistance in anaerobic bacteria: worrisome developments. Clin Infect Dis 39 (2004) 92-97
22. Kitzis M.D. In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother 25 A (1990) 15-18
23. Liu W.C. Bacteriology and antibiotic susceptibility of community-acquired intraabdominal infection in children. J Microbiol Immunol Infect 39 (2006) 249-254
24. Loivukene K., and Naaber P. Antibiotic susceptibility of clinically relevant anaerobes in Estonia from 1999 to 2001. Anaerobe 9 (2003) 57-61
25. Mastrantonio P., Spigaglia P., and Sebastianelli A. Susceptibility patterns and characterization of beta-lactamases in clinical isolates of Bacteroides fragilis. Eur J Clin Microbiol Infect Dis 13 (1994) 475-480
26. Munro R. Patterns of resistance to anaerobic organisms in Australia. Diagn Microbiol Infect Dis 12 (1989) 159S-163S
27. Nagy E., Szoke I., Gacs M., and Csiszar K. Antibiotic susceptibility of Bacteroides fragilis group strains in Hungary. Anaerobe 1 (1995) 269-274
28. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 6th ed. (2004), NCCLS, Villanova, PA (Document no. M11-A6)
29. Phillips I., King A., Nord C.E., and Hoffstedt B. Antibiotic susceptibility of the Bacteroides fragilis group. Eur J Clin Microbiol Infect Dis 11 (1992) 292-304
30. Roberts S.A. Antimicrobial susceptibility of anaerobic bacteria in New Zealand:1999-2003. J Antimicrob Chemother 57 (2006) 992-998
31. Rodloff A.C., Werner H., Kresken M., and Jansen A. German multicenter study on the in vitro susceptibility of Bacteroides species. Eur J Clin Microbiol Infect Dis 11 (1992) 1074-1080
32. Singer E., Calvet L., Mory F., Muller C., Chomarat M., Bézian M.C., et al. Monitoring of antibiotic resistance of gram-negative anaerobes. Med Mal Infect 38 (2008) 256-263
33. Snydman D.R. National survey of the susceptibility of Bacteroides fragilis group: report and analysis of trends in the United States from 1997 to 2004. Antimicrobial Agents Chemother 51 (2007) 1649-1655
34. Spangler SK, Jacobs MR, Appelbaum PC. Comparison of the E test and oxyrase methods in susceptibility testing of 201 Gram-negative and Gram-positive anaerobes to erythromycin, azithromycin, clarithromycin and roxithromycin. In: Abstracts of the Seventh European Congress of Clinical Microbiology and Infectious Diseases, Vienna, March 26-30, 1995, Abstract No. 171, p. 33.
35. Teng L.J. High incidence of cefoxitin and clindamycin ressistance among anaerobes in Taiwan. Antimicrobial Agents Chemother 46 (2002) 2908-2913
36. Watanabe K., Ueno K., Kato N., Muto Y., Bandoh K., Tanaka Y., et al. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan. Eur J Clin Microbiol Infect Dis 11 (1992) 1069-1073
37. Wexler H.M., and Finegold S.M. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria. Antimicrobial Agents Chemother 32 (1988) 403-406
38. Wybo L., Pierard D., Verschraegen I., Reynders M., Vandoorslaer K., Claeys G., et al. Third Belgian multicenter survey of antibiotic susceptibility of anaerobic bacteria. J Antimicrob Chemother 59 (2007) 132-139